News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galleon Pharmaceuticals, Inc. Names Lynne Brookes Senior Vice President and Chief Business Officer


12/1/2011 10:18:17 AM

HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing-control disorders, today announced the appointment of Lynne M. Brookes as senior vice president and chief business officer. She joins Galleon from Cephalon, Inc. where she held a variety of product management, marketing and business development positions and was most recently vice president of business development. She joined Cephalon in 1995 as a product manager and was responsible for commercializing many of Cephalon’s pharmaceutical products including PROVIGIL, the company’s most successful drug.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES